Dashboard
Manage Tickers

SRRKScholar Rock Holding Corp

Nasdaq scholarrock.com


$ 9.44 $ -0.40 (-4.07 %)    

Thursday, 06-Jun-2024 15:59:43 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 463.32 $ -0.16 (-0.03 %)
DIA $ 389.27 $ 0.80 (0.21 %)
SPY $ 534.63 $ -0.01 (0 %)
TLT $ 93.23 $ -0.14 (-0.15 %)
GLD $ 219.44 $ 1.61 (0.74 %)
$ 9.43
$ 9.95
$ 0.00 x 0
$ 9.47 x 456
$ 9.44 - $ 9.95
$ 5.93 - $ 21.17
557,786
na
904.27M
$ -0.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-19-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-07-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-19-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-scholar-rock-holding-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Scho...
06/04/2024 10:59:30

HC Wainwright & Co. analyst Andres Maldonado reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $30 ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/03/2024 20:31:11

scholar-rock-to-present-new-data-from-srk-181-phase-1-dragon-trial-at-asco-2024-annual-meeting
Scholar Rock To Present New Data From SRK-...
06/03/2024 20:01:14

Promising objective response rates (ORR) were observed in multiple tumor types in anti-PD-(L)1 resistant patientsAnalysis of ba...

scholar-rock-presents-new-data-from-srk-181-phase-1-dragon-trial-at-the-asco-annual-meeting
Scholar Rock Presents New Data From SRK-18...
05/28/2024 12:14:01

- Updated safety and efficacy results on SRK-181 will be featured in an oral presentation on Monday, June 3rd, at 1:50 p.m CDT/...

hc-wainwright--co-reiterates-buy-on-scholar-rock-holding-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Scho...
05/23/2024 10:19:03

HC Wainwright & Co. analyst Andres Maldonado reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $30 ...

scholar-rock-initiates-phase-2-embraze-trial-of-apitegromab-in-obesity-and-announces-new-preclinical-data-showing-srk-439-is-more-potent-than-an-anti-actrii-antibody-in-maintaining-lean-mass-in-diet-induced-obesity-dio-mice
Scholar Rock Initiates Phase 2 EMBRAZE Tri...
05/22/2024 11:05:47

hc-wainwright--co-reiterates-buy-on-scholar-rock-holding-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Scho...
05/08/2024 13:46:37

HC Wainwright & Co. analyst Andres Maldonado reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $30 ...

scholar-rocks-q1-cash-cash-equivalents-and-marketable-securities-of-238m-as-of-march-31-expected-to-support-runway-into-2h-2025
Scholar Rock's Q1 Cash, Cash Equivalents A...
05/07/2024 11:19:15

scholar-rock-holding-q1-2024-gaap-eps-059-misses-051-estimate
Scholar Rock Holding Q1 2024 GAAP EPS $(0....
05/07/2024 11:18:31

Scholar Rock Holding (NASDAQ:SRRK) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate o...

truist-securities-reiterates-buy-on-scholar-rock-holding-maintains-20-price-target
Truist Securities Reiterates Buy on Schola...
04/03/2024 13:42:55

Truist Securities analyst Srikripa Devarakonda reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $20 pr...

scholar-rock-is-a-potential-ma-target-its-exploration-of-obesity-market-garners-interest-analyst
Scholar Rock Is A Potential M&A Target, It...
03/28/2024 18:42:42

Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of k...

raymond-james-initiates-coverage-on-scholar-rock-holding-with-strong-buy-rating-announces-price-target-of-30
Raymond James Initiates Coverage On Schola...
03/28/2024 11:16:22

Raymond James analyst Gary Nachman initiates coverage on Scholar Rock Holding (NASDAQ:SRRK) with a Strong Buy rating and ann...

piper-sandler-maintains-overweight-on-scholar-rock-holding-maintains-28-price-target
Piper Sandler Maintains Overweight on Scho...
03/26/2024 12:27:09

Piper Sandler analyst Allison Bratzel maintains Scholar Rock Holding (NASDAQ:SRRK) with a Overweight and maintains $28 price...

truist-securities-reiterates-buy-on-scholar-rock-holding-maintains-20-price-target
Truist Securities Reiterates Buy on Schola...
03/25/2024 16:19:55

Truist Securities analyst Srikripa Devarakonda reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $20 pr...

hc-wainwright--co-reiterates-buy-on-scholar-rock-holding-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Scho...
03/19/2024 14:44:07

HC Wainwright & Co. analyst Andres Maldonado reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $30 ...

scholar-rock-reports-fy23-eps-loss-of-199-vs-226-yoy-and-cash-balance-of-2799m
Scholar Rock Reports FY23 EPS Loss of $(1....
03/19/2024 11:03:34

nio-reports-upbeat-earnings-joins-dave-v2x-riskified-and-other-big-stocks-moving-higher-on-tuesday
NIO Reports Upbeat Earnings, Joins Dave, V...
03/05/2024 15:56:57

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

scholar-rock-presents-new-preclinical-data-demonstrating-potential-benefit-of-srk-439-for-healthy-weight-loss-management
Scholar Rock Presents New Preclinical Data...
02/06/2024 13:15:21

Preclinical findings presented at Keystone Symposia show lean mass preservation, fat mass loss, and improved glucose metabolism...

scholar-rock-announces-presentation-of-new-preclinical-data-evaluating-srk-439-in-obesity-at-keystone-symposia
Scholar Rock Announces Presentation Of New...
01/25/2024 13:06:28

SRK-439 is a novel selective myostatin inhibitor designed for the treatment of cardiometabolic disordersPreclinical data suppor...

scholar-rock-announces-fda-clearance-of-ind-application-to-initiate-phase-2-proof-of-concept-trial-with-apitegromab-to-treat-obesity
Scholar Rock Announces FDA Clearance Of IN...
01/23/2024 13:02:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION